EuroPCR 2022: JenaValve TAVR System for the Treatment of Aortic Regurgitation | Prof Stephan Baldus

Watch on Radcliffe Cardiology: https://www.radcliffecardiology.com/video-index/europcr-22-jenavalve-tavr-system-treatment-aortic-regurgitation?utm_source=youtube&utm_medium=social_organic&utm_campaign=DELV-6599&utm_content=europcr_baldus2

Filmed at EuroPCR 2022, Prof Stephan Baldus (University of Köln Medical Center, DE) outlines the first results from a study investigating the use of the JenaValve TAVR device in treating patients with aortic regurgitation.

Discussion Points:
1. Prevalence and burden of aortic regurgitation
2. Treatment options
3. Importance of the technology
4. Considerations and further research

Recorded at EuroPCR 22, Paris.
Interviewer: Jonathan McKenna
Videographer: Oliver Miles
Editor: Jordan Rance

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.